Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

November 2027 87

  1. Primary completion Trial of CGM Technology in Persons Living With Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07639593

  2. Study completion AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684690

  3. Primary completion AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684690

  4. Study completion Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687212

  5. Primary completion Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07799129

  6. Primary completion Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07801599

  7. Study start Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07929467

  8. Study completion A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03811561

  9. Primary completion A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03811561

  10. Primary completion A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07555054

  11. Primary completion Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04347434

  12. Study completion A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668388

  13. Study completion PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05230446

  14. Study completion Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07237542

  15. Primary completion Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07237542

  16. Primary completion Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05308888

  17. Study completion A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07821944

  18. Primary completion A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07821944

  19. Primary completion Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Activities Following Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07759791

  20. Study completion Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06059144

  21. Study completion The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753555

  22. Primary completion The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753555

  23. Study completion Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05665608

  24. Primary completion Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05665608

  25. Study completion Evaluation and Prediction of the Effect of EECP on HR-NICE Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05718622

  26. Study completion Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05892510

  27. Study completion CGM Use in Adults With Type 2 Diabetes on Basal Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05944432

  28. Study completion Remote Ischemic Conditioning in Aneurysmal SAH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06032533

  29. Primary completion Remote Ischemic Conditioning in Aneurysmal SAH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06032533

  30. Study completion Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06170944

  31. Study completion High-definition Transcranial Electrical Stimulation for Upper Extremity Rehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06409143

  32. Primary completion Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06488105

  33. Study completion Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06743659

  34. Study completion TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06818084

  35. Primary completion TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06818084

  36. Study completion Virtual Reality's Impact on Upper Limb Function in Post-stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06881680

  37. Study completion Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07206290

  38. Primary completion Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07206290

  39. Study completion Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241520

  40. Primary completion VR Training to Improve Postoperative Cognitive Function in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07370844

  41. Study completion Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07412249

  42. Primary completion Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07412249

  43. Primary completion Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07601763

  44. Study completion A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07660796

  45. Primary completion TRADENT Scoring Balloon Versus Non-scoring Balloon for Lesion Preparation in DCB-Based Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899021

  46. Study completion A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07923357

  47. Primary completion A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07923357

December 2027 346

  1. Study completion Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04040452

  2. Study completion What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04436978

  3. Primary completion Alleviant ALLAY-HF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05685303

  4. Study completion Prophylactic Permanent Pacemaker in Patients With Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05889208

  5. Study completion MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06031428

  6. Primary completion MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06031428

  7. Study completion Polypill for Prevention of Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06143566

  8. Study completion AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06235112

  9. Primary completion Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06308952

  10. Study completion Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06440694

  11. Primary completion Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06440694

  12. Primary completion The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07062744

  13. Study completion Intrapleural Ropivacaine Infusion in Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07116343

  14. Study completion Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07180472

  15. Study completion Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07211035

  16. Study completion Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07247864

  17. Study completion Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07263308

  18. Primary completion Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279259

  19. Study completion Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07337577

  20. Study completion taVNS Combined With TENS on Motor Function in Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07425756

  21. Primary completion taVNS Combined With TENS on Motor Function in Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07425756

  22. Primary completion Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07499154

  23. Primary completion Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07607275

  24. Primary completion Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07939750

  25. Study completion Quality Improvement and Practice Based Research in Neurology Using the EMR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02670161

  26. Study completion Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02777593

  27. Primary completion Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02830152

  28. Study completion Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03183895

  29. Study completion Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03303612

  30. Primary completion Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03303612

  31. Study completion CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03455725

  32. Study completion PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03559114

  33. Primary completion Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03593317

  34. Study completion Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03603912

  35. Primary completion MitraClip REPAIR MR Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04198870

  36. Study completion CHAMPION-AF Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04394546

  37. Primary completion CHAMPION-AF Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04394546

  38. Study completion SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04511247

  39. Primary completion Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04700826

  40. Study completion SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04722250

  41. Study completion Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04754659

  42. Study completion Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04948749

  43. Primary completion Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04948749

  44. Primary completion Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04968509

  45. Study completion Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05111288

  46. Study completion GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05356104

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases Registry record

    Expected 2021-05; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04834089

  2. Primary completion Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. Registry record

    Expected 2021-05-31; that period ended on 2021-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04858308

  3. Primary completion Safety and Performance Study of the MitralStitch Repair System. Registry record

    Expected 2021-06-01; that period ended on 2021-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04080362

  4. Primary completion Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery Registry record

    Expected 2021-06-01; that period ended on 2021-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04223739

  5. Primary completion Post Marketing Clinical Trial to Demonstrate the Performance of the MedHub AutocathFFR Device. Registry record

    Expected 2021-06-01; that period ended on 2021-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04724057

  6. Study start Post Marketing Clinical Trial to Demonstrate the Performance of the MedHub AutocathFFR Device. Registry record

    Expected 2021-06-01; that period ended on 2021-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04724057

  7. Primary completion Study on the Relationship Between Asymmetric Vascular Sign of Cortex and Prognosis in Massive Cerebral Infarction Registry record

    Expected 2021-06-09; that period ended on 2021-06-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04247659

  8. Study completion Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation Registry record

    Expected 2021-06-11; that period ended on 2021-06-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04687111

  9. Primary completion Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation Registry record

    Expected 2021-06-11; that period ended on 2021-06-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04687111

  10. Primary completion Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION) Registry record

    Expected 2021-06-15; that period ended on 2021-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04734353

  11. Study start Comparative Evaluation of the McGrath Videolaryngoscope and the Direct Laryngoscopy for Tracheal Intubation in the Prehospital Setting Registry record

    Expected 2021-06-15; that period ended on 2021-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04930419

  12. Study completion Effect of Pioglitazone on T2DM Patients With COVID-19 Registry record

    Expected 2021-06-29; that period ended on 2021-06-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04604223

  13. Primary completion Effect of Pioglitazone on T2DM Patients With COVID-19 Registry record

    Expected 2021-06-29; that period ended on 2021-06-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04604223

  14. Primary completion Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection Registry record

    Expected 2021-06-30; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02547103

  15. Primary completion Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers Registry record

    Expected 2021-06; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02618837

  16. Primary completion Effect of Melatonin on Cardiometabolic Risk- FULL Registry record

    Expected 2021-06; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02681887

  17. Study completion Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis Registry record

    Expected 2021-06; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02722447

  18. Study completion A Study of The Femoral Popliteal Artery Treated With LEGFLOW OTW Registry record

    Expected 2021-06; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02965677

  19. Study completion Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization Registry record

    Expected 2021-06-30; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03268707

  20. Primary completion Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients. Registry record

    Expected 2021-06; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03797729

  21. Study completion Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. Registry record

    Expected 2021-06-30; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04046029

  22. Primary completion Chinese Medicine Treat for Hypertensive Renal Injury Registry record

    Expected 2021-06-30; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04078711

  23. Study completion Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms Registry record

    Expected 2021-06; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04532333

  24. Study start GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial Registry record

    Expected 2021-06-30; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04796428

  25. Study start Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy Registry record

    Expected 2021-06-30; that period ended on 2021-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04842838

  26. Study completion Remote ECG Monitoring of TAVI Patients Registry record

    Expected 2021-07-30; that period ended on 2021-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03810820

  27. Study completion GLP-1 Loading During Elective Percutaneous Coronary Intervention Registry record

    Expected 2021-07; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02127996

  28. Study completion Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure Registry record

    Expected 2021-07-31; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02137187

  29. Primary completion Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients. Registry record

    Expected 2021-07; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03551548

  30. Primary completion RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD Registry record

    Expected 2021-07; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03789695

  31. Primary completion Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT) Registry record

    Expected 2021-07-31; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04041167

  32. Primary completion PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI Registry record

    Expected 2021-07; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04045873

  33. Primary completion Coronavirus (COVID-19) ACEi/ARB Investigation Registry record

    Expected 2021-07-31; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04330300

  34. Study completion Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment Registry record

    Expected 2021-07; that period ended on 2021-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04641689

  35. Primary completion The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes Registry record

    Expected 2021-08-01; that period ended on 2021-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04535830

  36. Study completion Post Marketing Clinical Trial to Demonstrate the Performance of the MedHub AutocathFFR Device. Registry record

    Expected 2021-08-01; that period ended on 2021-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04724057

  37. Study completion Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke Registry record

    Expected 2021-08-30; that period ended on 2021-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04199455

  38. Primary completion Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis Registry record

    Expected 2021-08-30; that period ended on 2021-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04349683

  39. Study completion Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection Registry record

    Expected 2021-08; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02547103

  40. Primary completion Coronary Revascularization Versus Conservative Therapy in Patients With Treated Critical Limb Ischemia Registry record

    Expected 2021-08-31; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03712644

  41. Primary completion Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes Registry record

    Expected 2021-08-31; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04161170

  42. Primary completion Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris Registry record

    Expected 2021-08; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04270279

  43. Primary completion 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI Registry record

    Expected 2021-08-31; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570345

  44. Primary completion Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies Registry record

    Expected 2021-08; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04670809

  45. Study completion Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes Registry record

    Expected 2021-08; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04943692

  46. Primary completion Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes Registry record

    Expected 2021-08; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04943692

  47. Study start Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes Registry record

    Expected 2021-08; that period ended on 2021-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04943692

  48. Study start Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM Registry record

    Expected 2021-09-01; that period ended on 2021-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04682795

  49. Study completion Study on the Relationship Between Asymmetric Vascular Sign of Cortex and Prognosis in Massive Cerebral Infarction Registry record

    Expected 2021-09-09; that period ended on 2021-09-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04247659

  50. Study start Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke Registry record

    Expected 2021-09-13; that period ended on 2021-09-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05035953

  51. Study start Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery Registry record

    Expected 2021-09-20; that period ended on 2021-09-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03870516

  52. Study completion Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy Registry record

    Expected 2021-09; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02488252

  53. Study completion Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients. Registry record

    Expected 2021-09; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03551548

  54. Study completion Efficacy of Flash Glucose-Sensing Technology on the Occurrence of Cardiac Arrhythmias Associated With Hypoglycemia Registry record

    Expected 2021-09-30; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03570138

  55. Primary completion Efficacy of Flash Glucose-Sensing Technology on the Occurrence of Cardiac Arrhythmias Associated With Hypoglycemia Registry record

    Expected 2021-09-30; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03570138

  56. Primary completion A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation Registry record

    Expected 2021-09; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03950843

  57. Study completion DUAL Antithrombotic Therapy in Patients With AF and ACS Registry record

    Expected 2021-09-30; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04023630

  58. Study completion The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients Registry record

    Expected 2021-09; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04028544

  59. Study completion The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes Registry record

    Expected 2021-09-30; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04535830

  60. Study start Empagliflozin and Atrial Fibrillation Treatment Registry record

    Expected 2021-09; that period ended on 2021-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04583813

  61. Study completion Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes Registry record

    Expected 2021-10-01; that period ended on 2021-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03715582

  62. Study start Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction Registry record

    Expected 2021-10-01; that period ended on 2021-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04063345

  63. Primary completion Trial of EXenatide in Acute Ischaemic Stroke Registry record

    Expected 2021-10-04; that period ended on 2021-10-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03287076

  64. Study start The Flow Diverter for Treating Patients With Intracranial Aneurysms Registry record

    Expected 2021-10-17; that period ended on 2021-10-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05060185

  65. Study completion Cardiac Ganglionated Plexus Ablation Before Permanent Pacemaker Implantation in Patients With Sick Sinus Syndrome Registry record

    Expected 2021-10-27; that period ended on 2021-10-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04149886

  66. Study completion Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis Registry record

    Expected 2021-10-30; that period ended on 2021-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04349683

  67. Study completion Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study) Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02829151

  68. Primary completion Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study) Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02829151

  69. Primary completion Does the Advice to Eat a Mediterranean Diet With Low Carbohydrate Intake, Compared With a Low-fat Diet, Reduce Diabetes and Cardiovascular Disease? Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02938832

  70. Study completion Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02960126

  71. Study completion Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD) Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02966717

  72. Primary completion High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03403556

  73. Primary completion Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) Registry record

    Expected 2021-10-31; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03891277

  74. Study completion One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease Registry record

    Expected 2021-10-31; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04148820

  75. Primary completion One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease Registry record

    Expected 2021-10-31; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04148820

  76. Study completion Development and Evaluation of mHealth Solutions to Monitor and Involve Cardiometabolic Patients in Self-care Registry record

    Expected 2021-10-31; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04159558

  77. Primary completion Development and Evaluation of mHealth Solutions to Monitor and Involve Cardiometabolic Patients in Self-care Registry record

    Expected 2021-10-31; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04159558

  78. Study completion Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04270279

  79. Study start Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04817215

  80. Study start Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04907123

  81. Study start Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04970238

  82. Primary completion Mobile Health Application of Screening and Early Intervention for Prediabetic Patient at Primary Health Cares Setting Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04979559

  83. Study start Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05060588

  84. Study start A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05063253

  85. Study start Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05066620

  86. Study start Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions Registry record

    Expected 2021-10; that period ended on 2021-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05101005

  87. Study start Freestyle Libre and Hospital Admissions in Type 2 Diabetes Registry record

    Expected 2021-11-01; that period ended on 2021-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04997512

  88. Primary completion COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes Registry record

    Expected 2021-11-05; that period ended on 2021-11-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04723550

  89. Primary completion Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 Registry record

    Expected 2021-11-20; that period ended on 2021-11-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04161001

  90. Primary completion Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System Registry record

    Expected 2021-11-23; that period ended on 2021-11-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03788590

  91. Study completion Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes Registry record

    Expected 2021-11; that period ended on 2021-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01313533

  92. Study completion Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy Registry record

    Expected 2021-11; that period ended on 2021-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02594501

  93. Primary completion Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke Registry record

    Expected 2021-11-30; that period ended on 2021-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03519737

  94. Primary completion Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke Registry record

    Expected 2021-11; that period ended on 2021-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04285060

  95. Study start The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction Registry record

    Expected 2021-11; that period ended on 2021-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04912167

  96. Study completion Mobile Health Application of Screening and Early Intervention for Prediabetic Patient at Primary Health Cares Setting Registry record

    Expected 2021-11; that period ended on 2021-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04979559

  97. Study start Effect Of Semaglutide In Coronary Atheroma Plaque Registry record

    Expected 2021-11; that period ended on 2021-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05071417

  98. Study completion Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03715556

  99. Primary completion Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03721614

  100. Primary completion HELIOS China Registry: Evaluation of the HELIOS Stent in a Real-World Patient Population Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03916432